2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary

This publication has 201 references indexed in Scilit:

• Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease
  The American Journal of Human Genetics, 2009
• Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
  American Heart Journal, 2007
• ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
  JACC, 2007
• RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
  The Lancet, 2007
• Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections
  The Journal of Thoracic and Cardiovascular Surgery, 2006
• Takayasu’s arteritis: Operative results and influence of disease activity
  Journal of Vascular Surgery, 2006
• Level of Awareness of on-Treatment Patients About Prescribed Statins
  Cardiovascular Drugs and Therapy, 2004
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  JACC, 2004
• Ten novelFBN2mutations in congenital contractural arachnodactyly: Delineation of the molecular pathogenesis and clinical phenotype
  Human Mutation, 2001
• Two-dimensional echocardiographic aortic root dimensions in normal children and adults
  The American Journal of Cardiology, 1989